Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
56.75B | 56.06B | 44.32B | 37.59B | 34.76B | Gross Profit |
31.32B | 30.04B | 25.01B | 20.85B | 19.36B | EBIT |
2.24B | 2.11B | 1.87B | 2.45B | 1.56B | EBITDA |
4.52B | 5.23B | 4.67B | 4.24B | 3.08B | Net Income Common Stockholders |
1.06B | 1.04B | 973.00M | 1.13B | 696.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
5.57B | 5.55B | 5.74B | 6.50B | 4.22B | Total Assets |
63.08B | 60.75B | 60.59B | 44.64B | 40.62B | Total Debt |
14.74B | 14.83B | 15.97B | 9.31B | 7.94B | Net Debt |
9.18B | 9.29B | 10.23B | 2.81B | 3.71B | Total Liabilities |
48.57B | 46.63B | 46.66B | 31.85B | 28.82B | Stockholders Equity |
12.70B | 12.41B | 12.21B | 11.14B | 10.34B |
Cash Flow | Free Cash Flow | |||
3.39B | 2.71B | 248.00M | 1.04B | 758.00M | Operating Cash Flow |
5.38B | 5.34B | 2.98B | 3.58B | 3.41B | Investing Cash Flow |
-3.48B | -2.33B | -8.63B | -1.24B | -1.60B | Financing Cash Flow |
-2.07B | -3.40B | 4.85B | -284.00M | -1.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | €14.45B | 13.65 | 8.49% | 5.25% | 1.24% | 2.36% | |
77 Outperform | €11.62B | 10.84 | 15.80% | 3.92% | 7.37% | 3.85% | |
75 Outperform | €70.15B | 14.68 | 16.75% | 3.77% | 4.08% | 3.07% | |
74 Outperform | €49.35B | 17.45 | 11.75% | 2.23% | -2.86% | 8.16% | |
66 Neutral | $4.49B | 12.34 | 5.40% | 248.65% | 4.13% | -12.33% | |
63 Neutral | €12.88B | 16.11 | 2.50% | 5.06% | 7.36% | -64.31% | |
49 Neutral | €14.95B | 157.21 | 0.62% | 1.30% | 17.22% | ― |